M1A.139
Lead-induced chronic gout, unspecified wrist
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced chronic gout is a rare form of gout caused by long-term exposure to lead, a heavy metal that can accumulate in the body. When it affects the wrist, it can lead to persistent joint pain, swelling, and joint damage. This condition is classified under the ICD-10 code M1A.139. Recognizing the link between lead exposure and gout is crucial for proper diagnosis and management, especially for individuals with a history of occupational or environmental lead contact.
Causes & Symptoms
Clinical Causes: Prolonged exposure to lead through occupational settings such as mining, construction, or manufacturing Environmental exposure to lead-based paints or contaminated water sources Ingestion of lead-contaminated substances or contaminated food Inadequate safety measures in workplaces handling lead materials Genetic factors that may predispose individuals to lead accumulation or gout
Key Symptoms: Persistent pain and tenderness in the wrist joint Swelling and redness around the affected joint Reduced range of motion in the wrist Presence of tophi, which are deposits of uric acid crystals, under the skin around the joint Recurrent gout attacks that may become more frequent over time Possible joint deformities due to chronic inflammation and tissue damage
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical history review, including past exposure to lead. Physical examinations focus on joint swelling and deformities. Laboratory tests are essential and may include: - Blood lead level measurement to assess lead exposure - Serum uric acid level to confirm gout - Joint fluid analysis to detect uric acid crystals Imaging studies such as X-rays can reveal joint damage and tophi. A combination of these assessments helps distinguish lead-induced gout from other forms of gout and identify the contribution of lead exposure.
Treatment Protocols: Management of lead-induced gout typically involves: - Eliminating or reducing exposure to lead sources - Medications to manage pain and inflammation, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids - Uric acid-lowering therapies, including allopurinol or febuxostat, to decrease the formation of uric acid crystals - Chelation therapy may be considered in severe lead poisoning cases to remove excess lead from the body - Lifestyle modifications, such as dietary changes to reduce purine intake and staying well-hydrated Regular medical follow-up is essential to monitor both gout symptoms and lead levels, ensuring effective management of this complex condition.
Clinical Advice & FAQs
Billing Guidance
Is M1A.139 a billable ICD-10 code?
Yes, M1A.139 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.139?
Clinical documentation must specify the nature of Lead-induced chronic gout, unspecified wrist and any associated comorbidities for accurate reporting.
Cite this Clinical Reference